Rapid initiation of direct-acting antivirals and hepatitis C treatment outcomes in people with HIV: A real-world integrated care model
These findings highlight the feasibility and effectiveness of integrated HIV and HCV care in facilitating rapid DAA initiation in real-world setting. Scaling up this approach may help advance HCV elimination goals, especially among key populations with ongoing transmission risk.
Authors
- Ling-Ya Chen (ORCID: https://orcid.org/0000-0001-8271-6595)
- Hsi‐Yen Chang (ORCID: https://orcid.org/0009-0009-8430-5373)
- W. Liu
- Kuan‐Yin Lin (ORCID: https://orcid.org/0000-0001-6877-5345)
- L Y Tsai
- Yang Huang (ORCID: https://orcid.org/0000-0002-6458-6069)
- Hsin‐Yun Sun (ORCID: https://orcid.org/0000-0003-0074-7721)
- Chien‐Ching Hung (ORCID: https://orcid.org/0000-0001-7345-0836)
- Huiju Li
- Pei‐Ying Wu (ORCID: https://orcid.org/0000-0002-8168-6125)
- Yi-Ting Chen (ORCID: https://orcid.org/0000-0002-6694-7729)
- Wen Chen (ORCID: https://orcid.org/0009-0005-3384-1505)
- Yu‐Zhen Luo (ORCID: https://orcid.org/0009-0000-3646-4745)
Institutions
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- International Journal of Antimicrobial Agents
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1016/j.ijantimicag.2025.107635
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 1.32